Stay updated with breaking news from Study Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotrophic lateral sclerosis (ALS) will be shared as...
Regulators are going to be looking for. >> well, the studies in israel did not really compare directly people who got boosted to those who did not. it compared people who got boosted to themselves. so how did they do before and after they were boosted? and that study design is kind of weak. you always want to do something in parallel and realtime, because then you really know that the exposures were the same. and the other thing that we don't really have yet from the israeli data is a full readout on the ultimate outcomes. because we saw from previous data, both in israel and here, that you ne...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
New data analysis suggests an investigational higher dose of SPINRAZA may lead to clinically meaningful improvements in motor functionA NURTURE study analysis shows 92 percent of children who initiated
Virtual Clinical Trials Market Research Report by Study Design (Expanded Access Trials, Interventional Trials, and Observational Trials), by Implication...